Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Biomarkers × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Neoplasms 3 Lung Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion 1 Pituitary Diseases 1 Pituitary ACTH Hypersecretion 1 Obesity 1 Myasthenia Gravis 1 Motor Activity 1 Lymphoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Cardiotoxicity 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Paclitaxel 79 Carboplatin 63 pembrolizumab 57 Bevacizumab 25 Cisplatin 23 Surveys and Questionnaires 20 Radiotherapy 19 Letrozole 19 Doxorubicin 18 olaparib 17 Megestrol Acetate 17 lenvatinib 16 Specimen Handling 16 dostarlimab 15 Taxes 15 Nivolumab 14 Observation 13 Metformin 13 Magnetic Resonance Spectroscopy 13 Docetaxel 13 Blood Specimen Collection 12 Fulvestrant 11 temsirolimus 10 durvalumab 10 Medroxyprogesterone Acetate 10 Brachytherapy 10 Biopsy 10 abemaciclib 9 Trastuzumab 9 Radiation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02543710 2017-03-28

Momatec2

Haukeland University Hospital

Phase 4 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡